Sort
48,018 grants matching “immunotherapy”
Role of Dendritic Cell-mediated T Cell Activation in Salt-sensitive Hypertension
$477,006Steven D Crowley · Duke University · R01 · FY2019 · HL
Metastatic Clonal Heterogeneity and its Impact on Melanoma Therapeutic Resistance
$476,960Willy Hugo · University Of California Los Angeles · R01 · FY2020 · CA
Virally-induced tumorigenesis controlled by the microbiota
$476,888Tatyana V. Golovkina · University Of Chicago · R01 · FY2020 · CA
Virally-induced tumorigenesis controlled by the microbiota
$476,888Tatyana V. Golovkina · University Of Chicago · R01 · FY2021 · CA
Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1
$476,885Rong Li · George Washington University · R01 · FY2020 · CA
Cellular Transduction with Replication-Competent Retrovirus Vectors
$476,828Noriyuki Kasahara · University Of California Los Angeles · R01 · FY2011 · CA
Immunotherapeutics Against Other Filovirus Threats
$476,806Jonathan R. Lai · Scripps Research Institute, The · U19 · FY2018 · AI
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$476,752Wei R. Chen · University Of Oklahoma · R01 · FY2023 · CA
Targeting defective necroptosis in colorectal cancer
$476,741Lin Zhang · University Of Southern California · R01 · FY2024 · CA
Molecular Basis of Parvoviral Target Cell Specificity
$476,736Peter Tattersall · Yale University · R01 · FY2008 · CA
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
$476,736Xinna Zhang · Indiana University Indianapolis · R01 · FY2024 · CA
HPV genomic structure in cervical cancer radiation response and recurrence detection
$476,719Jin Zhang · Washington University · R37 · FY2024 · CA
Cancer-cell specific therapy: photo-immunotherapy
$476,718Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
SOUTHWEST ONCOLOGY GROUP CA-13612
$476,677University Of Arizona · U10 · FY2003 · CA
Developing newly combined therapeutic strategies for mature B cell lymphoma
$476,638Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
$476,622Elias Sayour · University Of Florida · R37 · FY2022 · CA
Nanoparticles-mediated combination therapy for breast cancer
$476,617Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
eRapa for bladder cancer prevention
$476,606Robert Scott Svatek · University Of Texas Hlth Science Center · R01 · FY2023 · CA
Understanding the induction of T cell dysfunction in the context of lung cancer
$476,553Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2023 · CA
Targeting Post-Transplant Minimal Residual CD19+ ALL with Genetically-
$476,519Laurence J.n. Cooper · Beckman Research Institute/City Of Hope · P01 · FY2009 · CA
Targeting the Epigenome for Lung Cancer Therapy
$476,450David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2014 · CA
Role of IL-12 family cytokines in human autoimmune Uveitis
$476,448Charles E Egwuagu · National Eye Institute · ZIA · FY2019 · EY
Multiscale Computational Models Guided By Emerging Cellular Dynamics Quantification For Predicting Optimum Immune Checkpoint And Targeted Therapy Schedules
$476,442Trachette Jackson · University Of Michigan At Ann Arbor · U01 · FY2021 · CA
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA
$476,399Hsian-Rong Tseng · University Of California Los Angeles · P01 · FY2015 · CA
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA
$476,399Hsian-Rong Tseng · University Of California Los Angeles · P01 · FY2016 · CA